RxDoctor Payments Data

Victor Villalobos

Medical Oncology · Aurora, CONPI 1861649865

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $22,863 of the $25,584 with a category attached, or 89.4%.

$25,584in general payments, 2019–2025

Across 50 payments — averaging $511.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$15K
  • Daiichi Sankyo Inc.$10K
$587,050in research payments, 2019–2025

Across 61 payments — averaging $9623.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Products Limited$276K
  • AbbVie$180K
  • AstraZeneca$52K
  • Eli Lilly$42K
  • Karyopharm Therapeutics Inc.$26K
  • Blueprint Medicines Corporation$11K
  • plus $769 from 1 others

What the payments were for

  • Consulting fees$22,86389%
  • Travel & lodging$2,2969%
  • Food & beverage$4262%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly42$15,162
Daiichi Sankyo Inc.8$10,423

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,584 in reported general payments places this provider in the 80th percentile of 96 medical oncology providers in Colorado.

See all medical oncology providers in Colorado →

Other medical oncology in Aurora

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →